Cyient to Support Manufacturing of Critical Medical Technology in the Fight Against COVID-19

– Cyient’s Mysore facility to support manufacturing of COVID-19 diagnosis units and X-ray system assemblies

HYDERABAD, India, March 31, 2020 /PRNewswire/ — Cyient, a global engineering and technology solutions company, today announced that it has received clearance for its Mysore facility to run its MedTech manufacturing lines to support the production of medical equipment that is critical in the fight against COVID-19. 

Cyient is producing assemblies that are used in X-ray generators from GE Healthcare and diagnosis units from Molbio Diagnostics to enable rapid disease testing in India.

Mr. Rajendra Velagapudi, Senior Vice President and CEO, Cyient DLM, commented, “We are proud to support our customers in the healthcare industry at this critical time. We will continue to do everything we can to help reduce the impact of this crisis on our customers’ operations as they focus on delivering the technology needed to fight COVID-19 at a national and global level.”  

Cyient’s factory in Mysore, India, is dedicated to electronic manufacturing processes, including printed circuit board assemblies, cable harnesses, and box-builds that closely align with our core competence in electronic systems design, integration, and manufacturing services.

About Cyient:

Cyient (Estd: 1991, NSE: CYIENT) is a global engineering and technology solutions company. As a Design, Build, and Maintain partner for leading organizations worldwide, Cyient takes solution ownership across the value chain to help customers focus on their core, innovate, and stay ahead of the curve. The company leverages digital technologies, advanced analytics capabilities, and its domain knowledge and technical expertise, to solve complex business problems.

With over 15,000 employees globally, Cyient partners with customers to operate as part of their extended team in ways that best suit their organization’s culture and requirements. Cyient’s industry focus includes aerospace and defense, healthcare, telecommunications, rail transportation, semiconductor, geospatial, industrial, and energy.

For more information, please visit www.cyient.com.

Follow news about the company at @Cyient.                

Media Relations

Perfect Relations

Vishal Thapa

Mobile: +91 9701834446

Email: vthapa@perfectrelations.com

 

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/cyient-to-support-manufacturing-of-critical-medical-technology-in-the-fight-against-covid-19-301032580.html

SOURCE Cyient

Staff

Recent Posts

Castle Biosciences Announces Updates to its Board of Directors

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…

5 hours ago

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp.…

5 hours ago

Dermata to Present at the Emerging Growth Conference on April 3, 2024

- Dermata to provide a corporate update followed by a live question and answer session…

5 hours ago

CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN…

8 hours ago

Greenway Health and DrFirst Partner to Improve Medication Adherence and Improve Patient Outcomes through Technology

TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…

10 hours ago

NextGen Healthcare Named to Newsweek List of America’s Most Trustworthy Companies for Third Year in a Row

List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…

11 hours ago